What question did this study set out to answer?

This research aims to understand the role of Flotillin-2 in regulating CD8+ T cell activation and anti-tumor function.

Abstract LB136: Flotillin-2 suppresses CD8⁺T cell anti-tumor function by restricting T cell receptor nanoclustering and activation

View Full Paper

Ask AI

Bookmark

Authors

Investigation reveals Flotillin-2 limits CD8+ T cell anti-tumor response, suggesting new therapeutic strategies.

This research aims to understand the role of Flotillin-2 in regulating CD8+ T cell activation and anti-tumor function.
Utilized Flotillin-2 global knockout and T cell-specific knockout models.
Assessed tonic TCR signaling through flow cytometry.
Stimulated CD8+ T cells with dendritic cells and altered peptide ligands.
Analyzed TCR nanoclusters using super-resolution imaging.
Evaluated anti-tumor function in cancer models and during adoptive transfer.
Flot2-deficient CD8+ T cells exhibited heightened tonic TCR signaling.
Increased TCR nanocluster formation in Flot2-deficient cells was observed.
Flot2 deficiency improved tumor control in B16F10 and MC38 models.
Adoptive transfer of Flot2-silenced CD8+ T cells enhanced tumor response.

Moon et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark